ZNF268: A Potential Drug Target Or Biomarker (G10795)
ZNF268: A Potential Drug Target Or Biomarker
ZNF268 (ZNF268 variant 3) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ZNF268 is a non-coding RNA molecule that is expressed in various tissues and cells in the body. It is a part of the ZNF2 gene family, which is known for its role in the development and progression of various diseases.
The ZNF268 gene has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as well as in the regulation of cancer cell growth and survival.
One of the most promising aspects of ZNF268 is its potential as a drug target. By blocking the activity of ZNF268, researchers may be able to reduce the growth and survival of cancer cells, as well as improve the survival of neurodegenerative disease cells. This could lead to a reduction in the number of relapses and side effects associated with current treatments.
In addition to its potential as a drug target, ZNF268 has also been shown to be a potential biomarker for various diseases. By analyzing the expression of ZNF268 in different tissues and cells, researchers may be able to identify biomarkers for diseases such as cancer, neurodegenerative diseases, and psychiatric disorders. This could lead to earlier detection and more effective treatments for these diseases.
Overall, ZNF268 is a promising gene that has the potential to be a drug target or biomarker for various diseases. Further research is needed to fully understand its role in the development and progression of these diseases.
Protein Name: Zinc Finger Protein 268
Functions: Acts as a transcriptional repressor. Inhibits erythroid differentiation and tumor cell proliferation. Plays a role during ovarian cancer development and progression
The "ZNF268 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF268 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415
